Denali Therapeutics (DNLI) Asset Utilization Ratio (2018 - 2023)
Historic Asset Utilization Ratio for Denali Therapeutics (DNLI) over the last 7 years, with Q2 2024 value amounting to 0.0.
- Denali Therapeutics' Asset Utilization Ratio fell 9967.49% to 0.0 in Q2 2024 from the same period last year, while for Jun 2024 it was 0.0, marking a year-over-year decrease of 9967.49%. This contributed to the annual value of 0.25 for FY2023, which is 23391.26% up from last year.
- Per Denali Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.0 for Q2 2024, which was down 9967.49% from 0.22 recorded in Q1 2024.
- Over the past 5 years, Denali Therapeutics' Asset Utilization Ratio peaked at 0.28 during Q4 2023, and registered a low of 0.0 during Q2 2024.
- For the 5-year period, Denali Therapeutics' Asset Utilization Ratio averaged around 0.14, with its median value being 0.09 (2022).
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 75144.76% in 2021, then tumbled by 9967.49% in 2024.
- Denali Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.25 in 2020, then tumbled by 88.63% to 0.03 in 2021, then soared by 182.83% to 0.08 in 2022, then soared by 242.62% to 0.28 in 2023, then plummeted by 99.7% to 0.0 in 2024.
- Its Asset Utilization Ratio was 0.0 in Q2 2024, compared to 0.22 in Q1 2024 and 0.28 in Q4 2023.